Gene Therapy
If stem cell and gene therapy methods are proven successful in the future, the treatments shouldn’t be made available to individuals, wanting to increase memory and intellectual capacity for themselves or their children. And, in as much as gene therapy treats a lot of diseases like cystic fibrosis and haemophilia and that elements such as CRISPR-Cas9 can be used in boosting intelligence, gene therapy should never be used in increasing intellectual capacity ( Kozubek Jim, 41). With seventy-four genetic variants, it becomes challenging in identifying single nucleotides and leveraging their importance. Besides, Harvard Scientists such as William Castle have explained how boosting, for instance, embryo intellectual capacity has diverse side effects. Genetic variants have qualitative traits which could differ and in as much as one would love to establish heritability of intelligence; the variances are hard to pinpoint, causing pleiotropic effects. And, in as much as genetic enhancement is concerned, there are too much safety concerns to any enhancement.
On the other hand, in as much as gene therapy is expensive, individuals in need of the services or products should pay for them. Individuals are, therefore advised to explore ways of paying for the services. As explained by Dana-Farber from the Cancer Institute, gene therapy is essential in ameliorating different conditions and that it can never be a one-time treatment which makes it expensive (Dana-Farber, 31). And, in as much as it cost dozens of thousands, despite every individual having to pay for the treatments, they should explore various models of valuing and pricing to develop gene therapy.